Merck (NYSE: MRK), known as MSD outside the United States and Canada, welcomes Ontario's decision to include CAPVAXIVE® in its publicly funded adult immunization program. This addition helps expand ...

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae (S. pneumoniae) bacterium, also known as pneumococcus. Infection can result in pneumonia, infection of the blood (bacteremia ...

Please provide your email address to receive an email when new articles are posted on . Merck’s 21-valent pneumococcal vaccine Capvaxive was previously approved only for adults. The FDA expanded the ...

The survey comes several weeks after multiple organizations, including the Vaccine Integrity Project and the American Medical Association, announced their review of the safety and effectiveness of ...

The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. This vaccine replaces previously listed pneumococcal ...

Despite supporting vaccines, many U.S. adults forgo shots for influenza and other respiratory diseases because they are unclear about the recommendations, according to survey results released Thursday ...

The Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia. An ...

Despite early and adequate treatment, there can still be serious and potentially life-threatening complications arising from pneumococcal infection. Doctors will usually prescribe antibiotics for ...

A new study by University of Liverpool researchers reveals how resistance to bacteremic pneumonia is provided by a unique subset of lung T regulatory cells. The Bacterial Pathogenesis and Immunity ...

Pneumococcal disease is a serious bacterial infection that can cause symptoms including earache, ear discharge, sinus congestion, fever, headache ...

Merck welcomed Ontario's decision to include CAPVAXIVE® in its publicly funded adult immunization program. This addition helps expand access to pneumococcal immunization for eligible older adults in ...